Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElecosoft Regulatory News (ELCO)

Share Price Information for Elecosoft (ELCO)

Share Price is delayed by 15 minutes
Get Live Data
127.50    -2.50 (-1.92%)
Bid:
125.00
Ask:
130.00
Spread: 5.00 (4.00%)
Market Cap: £106.44m
ELCO Live PriceLast checked at - London Stock Exchange

Intraday Elecosoft Share Chart

Director/PDMR Shareholding

22 Jun 2012 17:33

RNS Number : 0134G
Eleco PLC
22 June 2012
 



Eleco plc

("Eleco" or the "Company")

 

Director's shareholding

 

Eleco confirms that John Ketteley, Executive Chairman, informed the Company on 18 June 2012 he acquired 1,411,517 ordinary shares of Eleco at a price of 7.55 pence each and that his wife also acquired 177,745 ordinary shares of Eleco at a price of 7.55 pence on that date. On 18 June 2012 John Ketteley's SIPP and his wife's SIPP also sold respectively 1,411,527 ordinary shares of Eleco and 177,725 ordinary shares of Eleco at 7.55 p. Following these transactions, the ordinary shares of Eleco attributable to Mr Ketteley remain 7,423,255, representing 12.24 per cent. of the Company's issued share capital.

 

Enquiries:

 

Eleco plc

www.eleco.com

John Ketteley, Executive Chairman

+44 (0)1920 443830

 

Cenkos Securities plc

Adrian Hargrave

 +44 (0) 207 397 8900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFLLQFXBBL
Date   Source Headline
3rd Jun 20267:00 amRNSAGM Statement and YTD FY26 Trading Update
1st Jun 20267:00 amRNSGrant of Options
29th May 20267:00 amRNSExercise of Options, PDMR Shareholding and TVR
20th May 20267:00 amRNSExercise of Options and TVR
7th May 20262:40 pmRNSAnnual Report, Notice of AGM and Dividend Date
6th May 20262:12 pmRNSHolding(s) in Company
28th Apr 20267:00 amRNSFinal Results
14th Apr 20267:00 amRNSNotice of Results and Company Presentations
10th Apr 20264:25 pmRNSDisposal of Subsidiary
26th Mar 202612:12 pmRNSHolding(s) in Company
10th Feb 20268:49 amRNSHolding(s) in Company
10th Feb 20267:00 amRNSAcquisition of Kivue for £2.3m
6th Feb 20262:42 pmRNSHolding(s) in Company
2nd Feb 20262:53 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSYear-end Trading Update
26th Jan 20267:00 amRNSExercise of Options and Total Voting Rights
10th Nov 20257:00 amRNS-RIndustry Award Wins
22nd Sep 20254:43 pmRNSExercise of Options, PDMR Shareholding and TVR
16th Sep 20257:00 amRNSInterim Results
12th Sep 20257:00 amRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSNotice of Results
7th Aug 20253:47 pmRNSExercise of Options and Total Voting Rights
24th Jul 20257:00 amRNSTrading Update
20th Jun 20257:00 amRNSDirector Dealing
5th Jun 20257:00 amRNSDirector Dealings
4th Jun 20257:00 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNSAGM Statement and Trading Update
14th May 20251:52 pmRNSHolding(s) in Company
12th May 20258:15 amRNSAnnual Report, Notice of AGM and Dividend Date
8th May 20257:00 amRNSInvestor Presentation via Investor Meet Company
6th May 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
1st May 20257:00 amRNSFinal Results
10th Mar 20254:06 pmRNSExercise of Options and Total Voting Rights
3rd Mar 20257:00 amRNSPDMR Shareholding and Total Voting Rights
28th Jan 20257:00 amRNSYear-end Trading Update
14th Jan 20257:00 amRNSAcquisition of PEMAC
3rd Dec 202412:21 pmRNSExercise of Options and Total Voting Rights
4th Oct 20243:45 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHalf-year Report
21st Aug 20247:00 amRNSNotice of Results and Investor Presentation
25th Jul 20247:00 amRNSTrading Update
10th Jun 20246:20 pmRNSExercise of Options and Total Voting Rights
10th Jun 20246:13 pmRNSShare Options - correction
6th Jun 20247:00 amRNSGrant of Options
4th Jun 20241:29 pmRNSResult of AGM
4th Jun 20247:00 amRNSAGM Statement and Q1 2023 Trading Update
2nd May 20243:15 pmRNSAnnual Report, Notice of AGM & Dividend Date
23rd Apr 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSAcquisition of Vertical Digital
8th Apr 20247:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.